https://www.live-feeds.com/feed/the-chatgpt-for-doctors-openevidence-was-valued-at-15-billion-in-a-new-funding-roundContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/the-chatgpt-for-doctors-openevidence-was-valued-at-15-billion-in-a-new-funding-roundhttps://www.live-feeds.com/feed/the-chatgpt-for-doctors-openevidence-was-valued-at-15-billion-in-a-new-funding-round#u86591Sun, 27 Sep 2026 19:00:06 +0000Medical search and clinical intelligence platform OpenEvidence achieved a $15 billion valuation following a new alternative financing round. The company, often described as a ChatGPT for doctors, secured $250 million in the recent transaction. Andreessen Horowitz and Byers Capital led the financing effort for the medical tech platform. The fresh capital influx highlights the rapid commercial growth and investor appetite for artificial intelligence tools tailored specifically to clinical professionals and healthcare providers.Why it mattersThe massive funding round underscores the rising demand